Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-1,41%
1 076,13
-15,38
-1,41%
—1 091,511 090,401 090,401 073,69——
SIXC
Communications
SIXC
Communications
SIXC
-0,55%
606,74
-3,37
-0,55%
—610,11610,11610,29606,17——
SIXE
Energy
SIXE
Energy
SIXE
+0,88%
1 248,82
+10,84
+0,88%
—1 237,981 237,831 252,411 225,03——
SIXI
Industrials
SIXI
Industrials
SIXI
-1,17%
1 724,36
-20,35
-1,17%
—1 744,711 740,951 747,291 721,57——
SIXM
Financials
SIXM
Financials
SIXM
-0,72%
635,59
-4,59
-0,72%
—640,18639,92643,19634,73——
SIXR
Staples
SIXR
Staples
SIXR
-0,76%
843,15
-6,43
-0,76%
—849,58845,27851,68839,47——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,55%
216,29
-1,19
-0,55%
—217,48217,48218,16215,51——
SIXT
Technology
SIXT
Technology
SIXT
+0,08%
3 263,41
+2,72
+0,08%
—3 260,693 273,363 287,813 240,78——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,34%
939,24
-3,21
-0,34%
—942,45939,39948,80933,98——
SIXV
Health care
SIXV
Health care
SIXV
-0,29%
1 462,56
-4,24
-0,29%
—1 466,801 464,701 467,191 458,36——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0,71%
2 380,40
-17,10
-0,71%
—2 397,502 395,032 412,012 370,64——
TNDM:NASDAQ
Tandem Diabetes Care Inc
19,87 USD
+2,32%
(+0,45) 1D
19,87 USD
0,00% (0,00)
After hours
Closed: 4-май, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TNDM...
Open
19,62 USD
High
20,44 USD
Low
19,15 USD
Mkt. cap
1,36 млд
Avg. vol.
1,68 млн
Volume
2,07 млн
52-wk high
29,65 USD
52-wk low
10,00 USD
EPS
-3,04 USD
Beta
1,64
Shares outstanding
68,50 млн
No. of employees
2 миң
News stories
From sources across the web
Profile
Tandem Diabetes Care, Inc. is an American medical device manufacturer based in San Diego, California. The company develops medical technologies for the treatment of diabetes and specifically insulin infusion therapy. Wikipedia
About Tandem Diabetes Care Inc
CEOJohn Sheridan
Employees2,5 миң
Foundedянв. 2006
Headquarters-
SectorMedical device
Websitetandemdiabetes.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025-ж. мар.
2025-ж. июн.
2025-ж. сен.
2025-ж. дек.
Revenue
234,42 млн
240,68 млн
249,25 млн
290,38 млн
Cost of goods sold
116,02 млн
114,82 млн
114,96 млн
122,92 млн
Cost of revenue
116,02 млн
114,82 млн
114,96 млн
122,92 млн
Research and development expenses
47,94 млн
48,12 млн
47,92 млн
46,07 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
104,97 млн
109,60 млн
106,44 млн
113,10 млн
Operating expense
152,90 млн
157,71 млн
154,36 млн
159,17 млн
Total operating expenses
268,92 млн
272,54 млн
269,32 млн
282,09 млн
Operating income
-34,49 млн
-31,86 млн
-20,06 млн
8,29 млн
Other non operating income
-107,00 миң
268,00 миң
9,00 миң
616,00 миң
EBT including unusual items
-122,09 млн
-57,72 млн
-25,14 млн
4,68 млн
EBT excluding unusual items
-35,70 млн
-37,77 млн
-22,34 млн
4,68 млн
Income tax expense
8,47 млн
-5,32 млн
-3,98 млн
5,27 млн
Effective tax rate
-6,94%
9,22%
15,82%
112,58%
Other operating expenses
-
-
-
-
Net income
-130,56 млн
-52,40 млн
-21,16 млн
-589,00 миң
Net profit margin
-55,69%
-21,77%
-8,49%
-0,20%
Earnings per share
-0,67
-0,48
-0,31
-0,01
Interest and investment income
4,30 млн
3,40 млн
3,20 млн
2,80 млн
Interest expense
-1,86 млн
-1,90 млн
-2,06 млн
-2,08 млн
Net interest expenses
2,44 млн
1,50 млн
1,14 млн
725,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-30,18 млн
-27,49 млн
-15,57 млн
12,79 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer